Publication | Closed Access
Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib.
39
Citations
20
References
2014
Year
High pre-treatment serum levels of one or both biomarkers are associated with poor outcome of patients with NSCLC treated with erlotinib.
| Year | Citations | |
|---|---|---|
Page 1
Page 1